Pharming Group (PHAR)
10.22
-0.38
(-3.59%)
USD |
NASDAQ |
Dec 27, 16:00
10.00
-0.22
(-2.15%)
After-Hours: 20:00
Pharming Group Profit Margin (Quarterly): -1.38% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| uniQure NV | -1.94K% |
| ProQR Therapeutics NV | -211.0% |
| Merus NV | -848.7% |
| argenx SE | 15.95% |
| Pharvaris NV | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -8.24% |
| Return on Assets | -4.08% |
| Return on Invested Capital | -5.33% |
| Gross Profit Margin (Quarterly) | 90.89% |
| Operating Margin (Quarterly) | 5.49% |
| Return on Net Operating Assets | -8.74% |